Four Abstracts Accepted for Oral Presentation at 11ICI
An abstract entitled "Sn-117m for metastatic bone cancer treatment-modernizing Sn-117m-DTPA for regulatory approval" was accepted for oral presentation by Serene…
Abstract Accepted for Presentation at SNMMI
An abstract entitled "Isotopes bound to an innate immune response molecule" has been accepted for poster presentation at the 2023…
Sn-117m Colloid Study in Dogs Published in Veterinary Radiology Ultrasound
Positive results of the canine elbow osteoarthritis study using Sn-117m based Synovetin OA are published in Veterinary Radiology Ultrasound. Clinical…
Development of HSA Sn-117m Initiated
Development of an improved high specific activity tin-117m-DTPA product was initiated at Isotherapeutics Group, an experienced radiopharmaceutical development company contracted…
Department of Energy Signs Contract to Produce HSA Sn-117m
The Department of Energy has entered into an agreement with Serene to produce high specific activity (HSA) Sn-117m to be…
Poster Accepted to ASIC 2022 Conference
A poster entitled “Localizing a Theranostic Isotope to Neuroinflammation” utilizing tin-117m linked to a new inflammation targeting molecule, has been…
First Patient Treated in NIH-Sponsored Phase 2 Clinical Trial of Bone Metastases Using Sn-117m-DTPA
The initial patient was successfully injected with Sn-117m-DTPA in an NIH-sponsored Phase 2 clinical trial of prostate cancer patients with…
IND approved by FDA for Phase 2 Study of Bone Metastases Using Sn-117m DTPA
The Food and Drug Administration has approved a Serene, LLC IND for the use of Sn-117m DTPA for prostate cancer…
Abstract Submitted to Alzheimer’s Association International Conference
An abstract entitled "Design and bio-distribution of an apoptosis-inducing RAGE binding molecule”, was submitted to the Alzheimer’s Association Interational Conference,…
Abstract Accepted for Platform Presentation at Alzheimer Society International Congress
An abstract entitled "Localizing a theranostic isotope to neuroinflammation" was accepted for platform presentation at the 2021 Alzheimer Society International…
Poster Presented Virtually at SNMMI
A poster entitled "A unique theranostic isotope and targeting molecule to treat equine laminitis" was presented virtually at the Society…
Sn-117m Publication in The Journal of Health Physics
A publication entitled "Radiation Safety Considerations in the Treatment of Canine Skeletal Conditions Using 153Sm, 90Y, and 117mSn" was published…
Five Presentations and Abstracts Presented at 10ICI
Five abstracts or presentations presented at 10ICI related to Sn-117m including "Harnessing Sn-117m for improved quality of life", "Electron therapy…
Serene Product Accepted into the National Cancer Institute Experimental Therapeutics Program
A human clinical trial using a new high specific activity formulation of tin-117m-DTPA has been accepted into the National Cancer…
Radiation Safety of Sm-153, Y-90, and Sn-117m Article in Press
The following article is in press: Wendt RE, Selting KA, Lattimer JC, Wong J, Simon J, Stevenson NR, Stearns SD.…
Three Sn-117m-related Abstracts Presented at EANM
Three abstracts were presentation to the European Association of Nuclear Medicine: oral presentation of "A Novel Sn-117m Colloid for Human…
Three Abstracts Accepted for Platform Presentation at 10ICI in Kuala Lampur
Three abstracts entitled “Localizing apoptosis-inducing Sn-117m to brain neuroinflammatory cells”, “A new radioisotope-based treatment for veterinary and human arthritis”, and…
Serene Receives Authority to Proceed With First Human RSO Clinical Trial in Canada
Serene has received authority to proceed with its first-in-human RSO Phase 1b trial in Canada, by Health Canada. The "No…
Two Abstracts Submitted to 10ICI
Two abstracts were submitted to the 10th International Conference on Isotopes on February 3-7, 2020, in Kuala Lampur. They are…
Peer-reviewed Sn-117m Article in Veterinary Radiology Ultrasound
An electronic publication entitled "Intraarticular injection of a tin-117m radiosynoviorthesis agent in normal canine elbows causes no adverse effects" by…
Three Abstracts Accepted for Presentation at EANM
Three abstracts have been accepted for presentation to the European Association of Nuclear Medicine entitled: “A Novel Sn-117m Colloid for…
Three Abstracts Submitted to EANM
Serene submitted three abstracts for presentation to the European Association of Nuclear Medicine entitled: "A Novel Sn-117m Colloid for Human…
Nigel Stevenson Presents at Theranostics Conference
Nigel Stevenson gave an oral presentation entitled “Production of Sn-117m in the BR2 high-flux reactor” for Bernard Ponsard at the…
Drs Doerr and Stevenson Present at the Canadian Association of Nuclear Medicine 2019
Drs Cynthia Doerr and Nigel Stevenson presented data at the Canadian Association of Nuclear Medicine 2019 Annual Meeting on February…
Presentation at the AVORS Annual Meeting
A presentation entitled "Long term therapy for chronic osetoarthritis associated with elbow dysplasia"was presented by JM Donecker at the American…
Abstract Submitted to Theranostics 2019
An abstract entitled Production of Sn-117m in the BR2 high-flux reactor has been submitted by Bernard Ponsard for presentation at the…
Jay Donecker Presents at ACVR
Chief Veterinary Officer Jay Donecker presented Canine Sn-117m colloid intra-articular injection release guidance at the American College of Veterinary Radiology Annual…
Nigel Stevenson Presents at EANM
Chief Operating Officer Nigel Stevenson presented A novel molecule for the systemic imaging and treatment of rheumatoid arthritis at the European…
Abstract Submitted to the CANM Annual Meeting
An abstract entitled “Misadministration of Sn-117m colloid during radiosynoviorthesis presents no safety concerns” was submitted to the Canadian Association of Nuclear…
Nigel Stevenson Presents at KARA Conference
Nigel Stevenson presented "Applications of Sn-117m and the potential world supply and demand” at the KARA Radiation Promotion Conference, September…
Jay Donecker Presents at the AVORE Annual Meeting
Dr Jay Donecker presented "Synovetin OA Results of Clinical Trials Using a Homogeneous Tin Colloid for Treatment of Elbow Ostoearthritis"…
Two Sn-117m Presentations Featured at SNMMI
Two platform presentations regarding Sn-117m were presented at the Society of Nuclear Medicine and Molecular Imaging in Philadelphia. One entitled…
Poster Accepted at EANM
An abstract by Nigel Stevenson entitled “A Novel Molecule for the Systemic Imaging and Treatment of Rheumatoid Arthritis”, was accepted for…
Nigel Stevenson Presents at the International Isotope Symposium
Dr Stevenson presented at a symposium entitles "Sn-117m—a new isotope for treating arthritis”, at the International Isotope Symposium, June 3-7,…
Abstract accepted for presentation at the AAPM
An abstract entitled "Monte Carlo Simulation of the Dose From Radiosynoviorthesis Using Sn-117m, Er-169, and Re-186 Including Stochastic Macrophage Motion",…
Two Sn-117m-related abstracts have been accepted for oral presentation at SNMMI
Two Sn-117m -related abstracts, "“Release of dogs following Sn-117m colloid intra-articular injections”, RE Wendt et. al, and “A Monte Carlo study of…
Abstract submitted to the International Isotope Society Symposium
An abstract entitled "Sn-117m --A new isotope for treating arthritis" has been submitted to the International Isotope Society Symposium in Prague,…
Five abstracts submitted to Society of Nuclear Medicine and Molecular Imaging
Members of Serene, LLC and others have submitted five abstracts related to Sn-117m.
Nigel Stevenson invited to lecture at the American Chemical Society Spring 2018 National Meeting
Nigel Stevenson has been invited to present a lecture entitled "Manufacturing and applications of Sn-117m in nuclear medicine" at the…
Nigel Stevenson invited to present at the American Physical Society Q2C
Nigel Stevenson will present a lecture entitled "Advances in the global use of isotopes for medicine, indistruy and environmental science",…
Cynthia Doerr is invited to present a lecture at the Canadian Association of Nuclear Medicine 2018 Annual Meeting
Cynthia Doerr is invited to present a lecture entitled "Experience using hiomogeneous Sn-117m colloid for RSO", at the Canadian Association…
Six Presentations Related to Sn-117m Were Presented at 9ICI in Doha Qatar
Six presentations related to Sn-117m were presented at the 9th International Conference on Isotopes in Doha, Qatar November 12-16, 2017,…
Nigel Stevenson is invited to lecture at the 39th High Country Nuclear Medicine Conference
Nigel Stevenson is invited to present a lecture entitled "Tin-117m: A new isotope and approach to radiosynoviorthesis and other therapies"…
Gilbert Gonzales Presents at the 2017 ICRT Conference in Vienna, Austria
Dr Gonzales presented the history and development of Serene, LLC, and its many products and opportunities related to Sn-117m.
Nigel Stevenson Presents at the 2017 ICRT Meeting in Vienna, Austria
Dr Stevenson discussed manufacturing of the homogeneous Sn-117m colloid as well as other Sn-117m-related products.
Cynthia Doerr Presents at the 2017 ICRT Conference in Vienna, Austria
Dr Doerr presented data related to the pre-clinical trials in rats and dogs related to homogeneous Sn-117m colloid, and human…
Convetra Inc Completes Enrollment of a Third Clinical Trial Using Synovetin-OA
Today Serene LLC's veterinary subsidiary, Convetra Inc, completed enrollment of a clinical trial involving reinjecting Synovetin-OA in client-owned dog with…
MWI Animal Health and Securos Surgical invest in Serene, LLC to advance novel new therapies toward commercialization
THE WOODLANDS, Texas. September 26, 2017—MWI Animal Health and Securos Surgical, both a part of AmerisourceBergen, have made an investment…
Six abstracts accepted for presentation at 9ICI conference in Doha, Qatar
Six abstracts related to Sn-117m have been accepted for either poster or platform presentation at the 9th International Conference on…
Convetra Inc Completes Enrollment of a Second Clinical Trial Using Synovetin-OA
Today, Serene LLC's veterinary subsidiary, Convetra Inc, completed enrollment of its second clinical trial using Synovetin-OA in client owned dogs…
Dr Nigel Stevenson Participates in a CME Event at the Society of Nuclear Medicine and Molecular Imaging
COO Dr Nigel Stevenson participated in a 90 minute CME event at the 2017 SNMMI Annual Meeting. In the CME…
Scientific Presentations at Society or Nuclear Medicine and Molecular Imaging in Denver
Serene attended the Society of Nucelar Medicine and Molecular Imaging Annual Meeting in Denver, Colorado, where two presentations were accepted:…
A Poster and an Oral Presentation Accepted at the Society for Nuclear Medicine and Molecular Imaging Annual Meeting
A poster entitled "External radiation exposure following Sn-117m colloid intra-articular injections," and an oral presentation entitled "A comparison of tissue…
Serene, LLC Completes Enrollment of Pivotal Canine Elbow Osteoarthritis Study of Synovetin OA
Serene is pleased to announce that it has completed the enrollment of a pivotal trial of its lead product, Synovetin…
Serene, LLC Featured in World Council on Isotopes February 2017 Newsletter
Serene, LLC was the featured company profile in the "My Biz in Isotopes" section of the February 2017 Newsletter edition.
Commercial Manufacturing Validation Nearing Completion
Serene's commercial manufacturing facility located at Theragenics Corporation is completing processes and procedures to supply Synovetin OA. Validations currently underway…
Serene Submits Two Abstracts to Society of Nuclear Medicine and Molecular Imaging Annual Meeting
Serene submitted two abstracts to SNMMI annual meeting June 10-14, 2017, in Denver Colorado. Abstracts are entitled "A comparison of…
Podium Presentation Accepted at the Veterinary Orthopedic Society Annual Meeting
An abstract entitled "Preclinical Evaluation of 117mSn Colloid as a Radiosynoviorthesis Agent for Treatment of Canine Elbow Joint Osteoarthrosis" has…
Podium Presentation Accepted at the Association for Veterinary Orthhopedic Research and Education Winter Meeting
Jay Donecker, VMD, will present a Podium Presentation entitled "Synovitis and Radiosynoviorthesis" at the Association for Veterinary Orthopedic Research and…
Serene Team Members Present Data at Major International Conference
Two posters and one oral presentation related to Serene data were presented at the World Association of Radiopharmaceutical and Molecular Therapy…
Serene COO Nigel Stevenson has been named Session Chairperson at 9ICI 2017
Serene Chief Operating Officer, Nigel Stevenson, has been named as a Session Chairperson at the 9th International Conference on Isotopes…
Serene COO Nigel Stevenson is President-Elect of WCI
Serene Chief Operating Officer, Nigel Stevenson, has been elected as President-elect of the World Council on Isotopes beginning November 2016.
Serene COO Elected as 4th President of WCI
Serene Chief Operating Officer, Nigel Stevenson, has been elected as 4th President of the World Council on Isotopes from November…
Martin Manco Joints Serene Team as Secretary and Chief Financial Officer
Serene, LLC, is pleased to announce the addition of Martin Manco, JD, MBA, who is responsible for finance, legal, and…
R-NAV, LLC Announces New Company Name: Serene, LLC
We are pleased to announce that we have changed our company name from R-NAV, LLC, to Serene, LLC.
Serene COO Nigel Stevenson Serves in Numerous Capacities at 8ICI 2016
Serene Chief Operating Officer, Nigel Stevenson, served as Member and Session Chairperson on the Technical Organization Committee of the 8th…
Four Abstracts Accepted for the 11th International Conference on Radiopharmaceutical Therapy
Four abstracts have been accepted for presentation, three as posters and one as an oral presentation, at the 11th Annual…
Abstract accepted for Oral Presentation at American College of Veterinary Radiology
The abstract "Preclinical evaluation of Sn-117m colloid as a radiosynoviorthesis agent for treatment of canine elbow joint osteoarthrosis", has been…
Pivotal Trial of Synovetin OA in Canine Elbow Osteoarthritis is Halfway Enrolled
The pivotal trial of Synovetin OA used to treat elbow osteoarthritis in dogs has now completed the midway point. Gulf…
2 Abstracts Accepted to European Association of Nuclear Medicine Conference
Two tin-117m-related abstracts have been accepted for presentation at the European Association of Nuclear Medicine 2016 Conference in Barcelona, Spain,…
Three presentations regarding tin-117m at Society of Nuclear Medicine and Molecular Imaging
Three presentations were given regarding tin-117m at SNMMI in San Diego today. The presentations are "A Comparison of Er-169 and…
Pivotal Trial in Canine Elbow Arthritis Now 25% Enrolled
Today R-NAV enrolled our 12th subject in a pivotal trial for the treatment of canine elbow osteoarthritis. The trial now…
Four Abstracts Submitted for the June SNMMI 2016 Annual Meeting in San Diego
R-NAV has submitted four abstracts for presentation to the Society for Nuclear Medicine and Molecular Imaging meeting in San Diego…
Abstract submitted to the Society of Nuclear Medicine and Molecular Imaging Conference
An abstract entitled "Retention and Biodistribution of Sn-117m Colloid in Intra-Articular Injections" was submitted to the Society of Nuclear Medicine…
Abstract submitted to the American Academy of Neurology 2016 Annual Meeting
An abstract entitled “Non-Invasive Therapy of Symptomatic High Grade Carotid Stenosis Using [Tin-117m]-DOTA-Annexin V” has been submitted to the American Academy…
Invited Presentation at the International Conference on Translational Research in Radio-Oncology | Physics for Health in Europe
Dr Nigel Stevenson is an invited speaker at the ICTR-PHE 2016. His topic is Manufacturing and Nuclear Medicine Applications of…
First Client-Owned Dog Successfully Injected With Homogeneous Tin Colloid
Our first customer, a young black German Shepherd named Mykonos, was treated with homogeneous tin colloid on October 14, 2015.…
Jay Donecker, VMD, Joins R-NAV Team as Chief Veterinary Officer
R-NAV is pleased to announce the addition of Jay Donecker, VMD, as chief Veterinary Officer. Dr. Donecker has been a…
Abstract Presented at the World Molecular Imaging Congress in Honolulu, Hawaii
An abstract entitled "Evaluation of Homogeneous Sn-117m Colloid Radiosynovectomy in Normal Dogs Using Scintigraphy, PET-MRI and Other Modalities" was presented…
Abstract Accepted for Presentation at the World Molecular Imaging Congress in Honolulu Hawaii
An abstract entitled "Evaluation of Homogeneous Sn-117m Colloid Radiosynovectomy in Normal Dogs Using Scintigraphy, PET-MRI and Other Modalities" was accepted…
Abstract Presented at the Society of Nuclear Medicine and Molecular Imaging in Baltimore Maryland
The abstract "Homogeneous Sn-117m Colloid Radiosynovectomy Results in Rat Models of Joint Disease" was presented as a poster in Baltimore,…
Abstract Accepted for Presentation at Pacifichem, Honolulu, HI
The abstract Novel Treatments for Arthritis in Humans and Animals Using the Theranostic Isotope Sn-117m: Colloids and Labeled Molecules, was…
Abstract Presented at the International Conference on Radiopharmaceutical Therapy at Innsbruck Austria
"Homogeneous Sn-117 Colloid—A Novel Radiosynovectomy Agent" was presented in an oral presentation session at ICRT in Innsbruck, Austria.
Publication in the Journal of Radioanalytical and Nuclear Chemistry
A full length publication entitled "Methods of Producing High Specific Activity Sn-117m With Commercial Cyclotrons" has been published in the…
Abstract accepted for presentation at ICRT
Abstract Homogeneous Sn-117m Colloid, a Novel Radiosynovectomy Agent is accepted for oral presentation at the 10th International Conference on Radiopharmaceutical…
Abstract accepted for presentation at ACNM/SNMMI, San Antonio, TX
A Novel Sn-117m Colloid for Radiosynovectomy was presented in an oral presentation session at the ACNM/SNMMI at San Antonio, Texas.
Serene COO Nigel Stevenson Serves on WCI
Serene Chief Operating Officer, Nigel Stevenson, serves as the Chairperson of the World Council of Isotopes Committee on Education and…
Abstract presented at the International Conference on Isotopes, Chicago, Illinois
Methods of Producing High Specific Activity Sn-117m with Commercial Cyclotrons was presented at an oral presentation session at the 8th International…
Serene COO Nigel Stevenson Serves on WCI
Serene Chief Operating Officer, Nigel Stevenson, is named to serve as Chairperson for the World Council on Isotopes Committee on…